Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

19.80
Delayed Data
As of Apr 27
 -0.10 / -0.50%
Today’s Change
7.05
Today|||52-Week Range
24.00
+32.89%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close19.90
Today’s open19.90
Day’s range19.70 - 20.00
Volume95,136
Average volume (3 months)232,759
Market cap$699.7M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)+19.30%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...0.000.00%
AMPHAmphastar Pharmaceut...-0.16-1.04%
OMEROmeros Corp+0.18+1.10%
VNDAVanda Pharmaceutical...-0.05-0.33%
Data as of 04/27/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts